Aerovate Therapeutics
AVTE
#9167
Rank
NZ$0.12 B
Marketcap
$4.47
Share price
0.00%
Change (1 day)
-86.55%
Change (1 year)

Aerovate Therapeutics (AVTE) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : NZ$18.49 Million

According to Aerovate Therapeutics's latest financial reports the company's total liabilities are NZ$18.49 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Aerovate Therapeutics - Total liabilities on balance sheet (from 2020 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31NZ$13.47 M212.63%
2021-12-31NZ$4.31 M-82.77%
2020-12-31NZ$25.02 M135.52%
2019-12-31NZ$10.62 M